Skip to main content
TipRanks
Go Ultimate75% OFF

Apyx Medical (BOV) Stock Forecast & Price Target

1 Followers
See the Price Targets and Ratings of:

BOV Analyst Ratings

Strong Buy
3Ratings
3Buy0Hold0Sell
Based on 3 analysts giving stock ratings to Apyx Medical in the past 3 months

BOV Stock 12 Month Forecast

€5.65▲(129.66% Upside)
Based on 3 Wall Street analysts offering 12 month price targets for Apyx Medical in the last 3 months. The average price target is EUR 5.65 with a high forecast of EUR 6.24 and a low forecast of EUR 5.35. The average price target represents a 129.66% change from the last price of EUR 2.46.
Highest Price Target€6.24Average Price Target€5.65Lowest Price Target€5.35

Detailed List of Analyst Forecasts​

Analyst Type
Ranks
Analyst Rating
Upside/ Downside
Action
Analyst forecasts for DE:BOV
Price TargetArticle
H.C. Wainwright€6.24buy153.84%UpsideReiterated11/06/26
BTIG€5.35buy117.57%UpsideReiterated11/05/26
Maxim Group€5.35buy117.57%UpsideReiterated11/05/26
Craig-Hallum€5.35buy117.57%UpsideReiterated05/08/26
Titan Partners€5.35buy117.57%UpsideReiterated04/14/26
Citizens JMP€7.14buy190.10%UpsideUpgraded11/12/25
Stocks with the Highest Top Analyst Consensus in the General Sector
STDNStandard Nuclear
SKHYSK Hynix
ITGITG Inc. Class A
LIMENeutron Holdings, Inc.
EROCERock

Find stocks in the General sector that are highly recommended by Top Performing Analysts.

Best Analysts Covering Apyx Medical

3 Months
David Turkaly
David TurkalyCitizens JMP
Success Rate10/18 ratings generated profit
56%
Average Return
+9.14%

Copying David Turkaly's trades and holding each position for 3 Months would result in 55.56% of your transactions generating a profit, with an average return of +9.14% per trade.

1 Year
Matt Hewitt
Matt HewittCraig-Hallum
Success Rate12/27 ratings generated profit
44%
Average Return
+38.70%

Copying Matt Hewitt's trades and holding each position for 1 Year would result in 44.44% of your transactions generating a profit, with an average return of +38.70% per trade.

2 Years
Matt Hewitt
Matt HewittCraig-Hallum
Success Rate18/27 ratings generated profit
67%
Average Return
+66.61%

Copying Matt Hewitt's trades and holding each position for 2 Years would result in 66.67% of your transactions generating a profit, with an average return of +66.61% per trade.

BOV Analyst Recommendation Trends

02468Dec 25Jan 26Feb 26Mar 26Apr 26May 26Jun 26Jul 26Aug 26Sep 26Oct 26Nov 26
Monthly rating counts for BOV
RatingJul 26Aug 26Sep 26Oct 26Nov 26
Strong Buy22324
Buy01110
Hold00000
Sell00000
Strong Sell00000
total23434

In the current month, BOV has received 4 Buy Ratings, 0 Hold Ratings, and 0 Sell Ratings. BOV average Analyst price target in the past 3 months is 5.65.

BOV Financial Forecast

€-2€-1.5€-1€-0.5€0Q1 2026Q3 2026Q4 2026
High€-0.02
Consensus€-0.03
Low€-0.04

BOV Earnings Forecast

Next quarter’s earnings estimate for BOV is -EUR 0.03 with a range of -EUR 0.04 to -EUR 0.02. The previous quarter’s EPS was -EUR 0.04. Its overall industry beat the EPS estimate 50.49% of the time in the past 12 months.

€11.2M€12.7M€14.3M€15.8M€17.3MQ1 2026Q3 2026Q4 2026
High€17.3M
Consensus€17.2M
Low€17.1M

BOV Sales Forecast

Next quarter’s sales forecast for BOV is EUR 17.18M with a range of EUR 17.10M to EUR 17.35M. The previous quarter’s sales results were EUR 12.56M. Its overall industry beat sales estimates 63.25% of the time in the past 12 months.

BOV Stock Forecast FAQ

What is DE:BOV’s average 12-month price target, according to analysts?
Based on analyst ratings, Apyx Medical’s 12-month average price target is €5.65.
What is DE:BOV’s upside potential, based on the analysts’ average price target?
Apyx Medical has 129.66% upside potential, based on the analysts’ average price target.
Can I see which stocks the top-ranking analysts are rating?
Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
How can I follow the stock ratings of top Wall Street analysts?
Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
Is Apyx Medical a Buy, Sell or Hold?
Apyx Medical has a consensus rating of Strong Buy, which is based on 3 buy ratings, 0 hold ratings and 0 sell ratings.
What is Apyx Medical’s share price target?
The average share price target for Apyx Medical is €5.65. This is based on 3 Wall Street analysts’ 12-month price targets, issued in the past 3 months. The highest analyst share price target is €6.24, and the lowest forecast is €5.35. The average share price target represents a 129.66% increase from the current price of €2.46.
What do analysts say about Apyx Medical?
Apyx Medical’s analyst rating consensus is a Strong Buy. This is based on the ratings of 3 Wall Street analysts.
How can I buy shares of Apyx Medical?
To buy shares of DE:BOV, you can open a brokerage account. See exclusive account opening deals on our Best Online Brokers page.